PsABIOnd Study and eDaily Substudy Design: Long-Term Effectiveness and Safety of Guselkumab and IL-17 Inhibitors in Routine Clinical Practice in Patients with Psoriatic Arthritis

INTRODUCTION: Randomised clinical studies in psoriatic arthritis (PsA) do not always reflect patients in routine clinical practice. Large-scale data from routine practice are needed to better understand drug persistence, effectiveness and long-term safety of therapeutic agents. METHODS: PsABIOnd is...

Descripción completa

Detalles Bibliográficos
Autores principales: Siebert, Stefan, Behrens, Frank, Lubrano, Ennio, Martin, Nicolas, Sharaf, Mohamed, Contré, Christine, Theander, Elke, Queiro, Rubén, Zimmermann, Miriam, Gossec, Laure
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011238/
https://www.ncbi.nlm.nih.gov/pubmed/36585602
http://dx.doi.org/10.1007/s40744-022-00518-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011238/
https://www.ncbi.nlm.nih.gov/pubmed/36585602
http://dx.doi.org/10.1007/s40744-022-00518-w

Ejemplares similares